No data available.
Please log in to see this content.
You have no subscription access to this content.
No metrics data to plot.
The attempt to load metrics for this article has failed.
The attempt to plot a graph for these metrics has failed.
Feasibility study of helical tomotherapy for total body or total marrow irradiationa)
1.B. Sabine, H. Claudine, C. Bernard, and M. Raymond, “Total body irradiation before allogeneic bone marrow transplantation: is more dose better?,” Int. J. Radiat. Oncol., Biol., Phys. 49, 1071–1077 (2001).
2.G. Socie et al., “Influence of the fractionation of total body irradiation on complication and relapse rate for chronic myelogenous leukaemia,” Int. J. Radiat. Oncol., Biol., Phys. 20, 397–404 (1991).
3.T. L. Morgan, P. M. Falk, N. Kogut, K. H. Shah, M. Tome, and A. R. Kagan, “A comparison of single dose and fractionated total-body irradiation on the development of pneumonitis following bone marrow transplantation,” Int. J. Radiat. Oncol., Biol., Phys. 36, 61–66 (1996).
4.J. M. Cosset, G. Socie, B. Dubray, T. Girinsky, A. Fourquet, and E. Gluckman, “Single dose versus fractionated total body irradiation before bone marrow transplantation: Radiobiological and clinical consideration,” Int. J. Radiat. Oncol., Biol., Phys. 30, 477–492 (1994).
5.D. Scarpati, F. Frassoni, V. Vitale, R. Corvo, P. Franzone, S. Barra, M. Guenzi, and M. Orsatti, “Total body irradiation in acute myeloid leukemia relapse,” Int. J. Radiat. Oncol., Biol., Phys. 17, 547–552 (1989).
6.A. D. Volpe, A. J. M. Ferreri, C. Annaloro, P. Mangili, A. Rosso, R. Calandrino, E. Villa, G. Lambertenghi-Deliliers, and C. Fiorino, “Lethal pulmonary complications significantly correlate with individual assessed mean lung dose in patients with hematologic malignancies treated with total body irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 52, 483–488 (2002).
7.Z. Weshler, R. Breuer, R. Or, E. Naparstek, M. R. Pfeffer, E. Lowental, and S. Slavin, “Interstitial pneumonitis after total body irradiation: Effects of total lung shielding,” Br. J. Haematol. 74, 61–64 (1990).
8.A. Barrett, “Relationship of irradiation to pulmonary complications,” Exp. Hematol. 12, 67 (1984).
9.T. J. Keane, J. Van Dyk, and W. Rider, “Idiopathic interstitial pneumonia following bone marrow transplantation: the relationship with total body irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 7, 1365–1370 (1981).
10.R. C. Tait, A. K. Burnett, A. G. Robertson, S. McNee, B. M. Riyami, R. Carter, and R. D. Stevenson, “Subclinical pulmonary function defects following autologous and allogeneic bone marrow transplantation: Relationship to total body irradiation and graft versus-host-disease,” Int. J. Radiat. Oncol., Biol., Phys. 20, 1219–1227 (1991).
11.B. Bruno, G. Souillet, Y. Bertrand, M. C. Werck-Gallois, A. So Satta, and G. Bellon, “Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre,” Bone Marrow Transplant 34, 143–147 (2004).
12.D. G. Cogan, D. D. Donaldson, and A. B. Reese, “Clinical and pathological characteristics of radiation cataract,” AMA Arch. Ophthalmol. 47, 55–70 (1952).
13.M. L. van Kempen-Harteveld, Y. Belkacémi, H. B. Kal, M. Labopin, and F. Frassoni, “Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia,” Int. J. Radiat. Oncol., Biol., Phys. 52, 1367–1374 (2002).
14.Y. Belkacemi, M. Ozsahin, F. Pene, B. Rio, J. P. Laporte, V. Leblond, E. Touboul, M. Schlienger, N. C. Gorin, and A. Laugier, “Cataractogenesis after total body irradiation,” Int. J. Radiat. Oncol., Biol., Phys. 35, 53–60 (1996).
15.D. L. Cooper, S. Seropian, and R. W. Childs, “Autologous and allogeneic stem cell transplant,” in Cancer: Principles and Practice of Oncology, 6th ed., edited by V. T. DeVita, S. Hellman, and S. A. Rosenberg (Lippincott, Williams & Wilkins, Philadelpia, 2001), pp. 2773–2798.
17.P. Rubin and G. W. Casarett, Clinical Radiation Pathology (Saunders, Philadelphia, 1968), Vols. 1 and 2.
18.R. Miralbell, G. Sancho, S. Bieri, I. Carrio, C. Helg, S. Brunet, P. Y. Martin, A. Sureda, G. Gomez De Segura, B. Chapuis, M. Estorch, M. Ozsahin, and A. Keller, “Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment,” Int. J. Radiat. Oncol., Biol., Phys. 58, 809–1816 (2004).
19.C. A. Lawton, E. P. Cohen, K. J. Murray, S. W. Derus, J. T. Casper, W. R. Drobyski, M. M. Horowitz, and J. E. Moulder, “Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation,” Bone Marrow Transplant 20, 1069–1074 (1997).
20.M. Hassan, P. Ljungman, O. Ringden, Z. Hassan, G. Oberg, C. Nilsson, A. Bekassy, M. Bielenstein, M. Abdel-Rehim, S. Georen, and L. Astner, “The effect of busulphan on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite: time interval influence on therapeutic efficacy and therapy-related toxicity,” Bone Marrow Transplant 25, 915–924 (2000).
21.J. H. Lee, K. H. Lee, S. J. Choi, Y. J. Min, J. G. Kim, S. Kim, J. S. Lee, S. H. Kim, C. J. Park, H. S. Chi, and W. K. Kim, “Veno-occlusive disease of the liver after allogeneic bone marrow transplantation for severe aplastic anemia,” Bone Marrow Transplant 26, 657–662 (2000).
22.T. Girinsky, E. Benhamou, J. H. Bourhis, F. Dhermain, D. Guillot-Valls, V. Ganansia, M. Luboinski, A. Perez, J. M. Cosset, G. Socie, D. Baume, N. Bouaouina, E. Briot, A. Beaudre, A. Bridier, and J. L. Pico, “Prospective randomized comparison of single-dose versus hyperfractionated total-body irradiation in patients with hematologic malignancies,” J. Clin. Oncol. 18, 981–986 (2000).
23.T. Murdych and D. J. Weisdorf, “Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977–1997,” Bone Marrow Transplant 28, 283–287 (2001).
24.L. M. Buja, V. J. Ferrans, and R. G. Graw, Jr., “Cardiac pathologic findings in patients treated with bone marrow transplantation,” Hum. Pathol. 7, 17–45 (1976).
25.W. Blum, H. Khoury, H. S. Lin, R. Vij, L. T. Goodnough, S. Devine, J. Dipersio, and D. Adkins, “Primary amyloidosis patients with significant organ dysfunction tolerate autologous transplantation after conditioning with single-dose total body irradiation alone: A feasibility study,” Biol. Blood Marrow Transplant 9, 397–404 (2003).
26.J. R. Cunningham and D. J. Wright, “A simple facility for whole body irradiation,” Radiology 78, 941–949 (1962).
28.M. Pla, S. G. Chenery, and E. B. Podgorsak, “Total body irradiation with a sweeping beam,” Int. J. Radiat. Oncol., Biol., Phys. 9, 83–89 (1983).
29.AAPM (American Association of Physicists in Medicine. “The physical aspects of Total and Half Body photon Irradiation,” in AAPM Report No. 17, Chairman: J. Van Dyk, American Institute of Physics, New York, 1986.
30.B. J. Gerbi and K. E. Dusenbery, “Design specifications for a treatment stand used for total body photon irradiation with patients in a standing position,” Med. Dosim 20, 25–30 (1995).
31.T. E. Wheldon, “The radiological basis of total body irradiation,” Br. J. Radiol. 70, 1204–1207 (1997);
31.G. G. Steel and T. E. Wheldon, “The radiation biology of paediatric tumours,” in Paediatric Oncology, edited by R. Pinkerton and N. Plowman (Wiley, London, 1991).
32.S. K. Hui, D. Henderson, R. K. Das, and B. Thomadsen, “CT based analysis of dose homogeneity in total body irradiation using lateral beam,” J. Appl. Clin. Med. Phys. 5, 1–9 (2004).
33.J. E. Anderson, F. R. Appelbaum, G. Schoch, T. Barnett, T. R. Chauncey, M. E. Flowers, and R. Storb, “Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation,” Biol. Blood Marrow Transplant 7, 163–170 (2001).
34.L. L. van Kempen-Harteveld, M. H. van Weel-Sipman, C. Emmens, E. M. Noordijk, I. van der Tweel, T. Revesz, H. Struikmans, H. B. Kal, A. van der Does-van den Berg, and J. M. Vossen, “Eye shielding during total body irradiation for bone marrow transplantation in children transplanted for a hematological disorder: Risks and benefits,” Bone Marrow Transplant 31, 1151–1156 (2003).
35.G. H. Olivera, D. M. Shepard, P. J. Reckwerdt, K. Ruchala, J. Zachman, E. E. Fitchard, and T. R. Mackie, “Maximum likelihood as a common computational framework in tomotherapy,” Phys. Med. Biol. 43, 3277–3294 (1998).
36.J. S. Welsh, R. R. Patel, M. A. Ritter, P. Harari, T. R. Mackie, and M. P. Mehta, “Helical Tomotherapy: An Innovative Technology and Approach to Radiation Therapy,” Technology in Cancer Research and Treatment 1, 55–63 (2002).
37.T. R. Mackie, J. Kapatoes, K. Ruchala, W. Lu, C. Wu, G. Olivera, L. Forrest, W. Tome, J. Welsh, R. Jeraj, P. Harari, P. Reckwerdt, B. Paliwal, M. Ritter, H. Keller, J. Fowler, and M. Mehta, “Image guidance for precise conformal radiotherapy,” Int. J. Radiat. Oncol., Biol., Phys. 56, 89–105 (2003).
38.J. M. Kapatoes, G. H. Olivera, K. J. Ruchala, J. B. Smilowitz, P. J. Reckwerdt, and T. R. Mackie, “A feasible method for clinical delivery verification and dose reconstruction in tomotherapy,” Med. Phys. 28, 528–542 (2001).
40.K. E. Dusenbery, M. Steinbuch, P. B. McGlave, N. K. Ramsay, B. R. Blazar, J. P. Neglia, C. Litz, J. H. Kersey, and W. G. Woods, “Autologous bone marrow transplantation in acute myeloid leukemia: The University of Minnesota experience,” Int. J. Radiat. Oncol., Biol., Phys. 36, 335–343 (1996).
41.C. S. Mayo and M. M. Urie, “A systematic benchmark method for analysis and comparison of IMRT treatment planning algorithms,” Med. Dosim 28, 235–242 (2003).
42.K. J. Ruchala, G. H. Olivera, J. M. Kapatoes, E. A. Schloesser, P. J. Reckwerdt, and T. R. Mackie, “Megavoltage CT image reconstruction during tomotherapy treatments,” Phys. Med. Biol. 45, 3545–3562 (2000).
43.J. S. Welsh, K. Bradley, K. J. Ruchala, T. R. Mackie, R. Manon, R. Patel, P. Wiederholt, M. Lock, S. Hui, and M. P. Mehta, “Megavoltage computed tomography imaging: a potential tool to guide and improve the delivery of thoracic radiation therapy,” Clin Lung Cancer 5, 303–306 (2004).
44.O. Thomas, M. Mahe, L. Campion, S. Bourdin, N. Milpied, G. Brunet, A. Lisbona, A. Le Mevel, P. Moreau, J. Harousseau, and J. Cuilliere, “Long-term complications of total body irradiation in adults,” Int. J. Radiat. Oncol., Biol., Phys. 49, 125–131 (2001).
46.T. E. Schultheiss, A. Liu, G. Olivera, J. Kapatoes, and J. Wong, “Total marrow and total lymphatic irradiation with helical tomotherapy,” Med. Phys. 31, 1845 (2004).
47.F. R. Appelbaum et al., “The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia,” Transplantation 54, 829–833 (1992).
48.D. Hawkins, T. Barnett, W. Bensinger, T. Gooley, and J. Sanders, “Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors,” Med. Pediatr. Oncol. 34, 328–337 (2000).
49.R. A. Clift, C. Dean Buckner, F. R. Appelbaum, E. Bryant, S. I. Bearman, F. B. Petersen, L. D. Fisher, C. Anasetti, P. Beatty, W. I. Bensinger, K. Doney, R. S. Hill, G. B. McDonald, P. Martin, J. Meyers, J. Sanders, J. Singer, P. Stewart, K. M. Sullivan, R. Witherspoon, R. Storb, J. A. Hansen, and E. Donnall Thomas, “Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: A randomized trial of two irradiation regimens,” Blood 77, 1660–1665 (1991).
50.R. Corvo, T. Lamparelli, B. Bruno, S. Barra, M. T. Van Lint, V. Vitale, and A. Bacigalupo, “Low-dose fractionated total body irradiation (TBI) adversely affects prognosis of patients with leukemia receiving an HLA-matched allogeneic bone marrow transplant from an unrelated donor (UD-BMT),” Bone Marrow Transplant 30, 717–723 (2002).
51.T. J. FitzGerald et al., “Effect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: Evidence for heterogeneity,” Int. J. Radiat. Oncol., Biol., Phys. 12, 69–73 (1986).
52.J. G. Rhee, C. W. Song, T. H. Kim, and S. H. Levitt, “Effect of fractionation and rate of radiation dose on human leukemic cells, HL-60,” Radiat. Res. 101, 519–527 (1985).
53.N. Tarbell J, D. A. Amato, J. D. Down, P. Mauch, and S. Hellman, “Fractionation and dose rate effects in mice: A model for bone marrow transplantation in man,” Int. J. Radiat. Oncol., Biol., Phys. 13, 1065–1069 (1987).
54.J. M. Cosset, G. Socie, T. Girinsky, B. Dubray, A. Fourquet, and E. Gluckman, “Radiobiological and clinical bases for total body irradiation in the leukemias and lymphomas,” Semin. Radiat. Oncol. 5, 301–315 (1995).
55.T. Girinsky, G. Socie, H. Ammarguellat, J. M. Cosset, E. Briot, A. Bridier, and E. Gluckman, “Consequences of two different doses to the lungs during a single dose of total body irradiation: results of a randomized study on 85 patients,” Int. J. Radiat. Oncol., Biol., Phys. 30, 821–824 (1994).
57.D. Cowen, P. Richaud, G. Marit, P. Cony-Makhoul, R. Trouette, C. Faberes, and J. Reiffers, “Regimen-related toxicity in patients undergoing BMT with total body irradiation using a sweeping beam technique,” Bone Marrow Transplant 10, 515–519 (1992).
58.S. A. Carruthers and M. M. Wallington, “Total body irradiation and pneumonitis risk: A review of outcomes,” Br. J. Cancer 90, 2080–2084 (2004).
59.M. Beyzadeoglu, K. Oysul, B. Dirican, F. Arpaci, A. Balkan, S. Surenkok, and Y. Pak, “Effect of dose-rate and lung dose in total body irradiation on interstitial pneumonitis after bone marrow transplantation,” Tohoku J. Exp. Med. 202, 255–263 (2004).
60.H. J. Dobbs, A. Barrett, A. Y. Rostom, and M. J. Peckham, “Total-body irradiation in advanced non-Hodgkin"s lymphoma,” Br. J. Radiol. 54, 878–881 (1981).
62.T. Zhang, R. Jeraj, H. Keller, W. Lu, G. H. Olivera, T. R. McNutt, T. R. Mackie, and B. Paliwal, “Treatment plan optimization incorporating respiratory motion,” Med. Phys. 31, 1576–86 (2004).
Article metrics loading...
Full text loading...
Most read this month